Invest Daily Pro
  • Economy
  • Investing
No Result
View All Result
  • Economy
  • Investing
No Result
View All Result
Invest Daily Pro
No Result
View All Result
Home Economy

Vet Planet Ltd. and Cancan Diagnostics Join Forces to Bring Revolutionary Canine Cancer Diagnostic Tools to Market

by
September 13, 2024
in Economy, Investing
0
Vet Planet Ltd. and Cancan Diagnostics Join Forces to Bring Revolutionary Canine Cancer Diagnostic Tools to Market
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

Cancan Diagnostics, a leading provider of innovative diagnostic solutions for canine cancer, is pleased to announce a strategic distribution partnership with Vet Planet Ltd., a renowned veterinary products and services company based in Poland. This collaboration will expand Cancan’s reach to 47 territories across Mainland Europe, APAC, Middle East, and South America.

Cancan Diagnostics is dedicated to advancing canine health and has developed K9-LiquiDX™, a cutting-edge diagnostic tool specifically designed for minimal residual disease testing in dogs. This groundbreaking test offers unparalleled early relapse detection and support for monitoring canine cancer.

The partnership with Vet Planet Ltd. marks a significant milestone in Cancan’s global expansion, ensuring that veterinarians worldwide have access to innovative tools that enhance the overall experience for pets and their owners while improving the accuracy and speed of cancer diagnosis in dogs.

“We are delighted to partner with Vet Planet Ltd., a highly respected company in the European veterinary market,” stated Dr. Maciej Parys, CEO and Founder of Cancan Diagnostics. “Their extensive distribution network and commitment to veterinary excellence align perfectly with our mission to improve canine cancer care through advanced diagnostics. Together, we can make a significant impact on the detection and management of cancer in dogs worldwide.”

Vet Planet Ltd., known for its exceptional service and dedication to the veterinary community, will play a crucial role in ensuring that Cancan Diagnostics’ innovative products reach veterinarians across 47 territories. This partnership reflects a shared vision of enhancing pet health through advanced, reliable, and accessible diagnostic solutions.

“Our brand, Vet Expert, incorporates the term ‘Based on evidence’ in its logo, reflecting our approach to developing innovative, effective, and first-in-class products and solutions,” said Lukasz Deneka, DVM, Category Development Manager of Diagnostics at Vet Planet Ltd. “Our partnership with Cancan Diagnostics perfectly aligns with our mission of caring for animal health and welfare. The cooperation will undoubtedly enrich our offering with a cutting-edge diagnostic solution, distributed under the name of Vet Expert K9-LiquiDX Canine Cancer Check.”

Cancan Diagnostics and Vet Planet Ltd. are excited to work closely together to provide veterinarians with the tools they need to make a real difference in the lives of dogs affected by cancer.

For more information about Cancan Diagnostics and its innovative solutions, please visit cancandiagnostics.com.

About Cancan Diagnostics

Cancan Diagnostics is a spin-out from the University of Edinburgh, specializing in innovative solutions for the diagnosis and monitoring of canine cancer. With a focus on improving pet health outcomes, Cancan’s products empower veterinarians with the latest technology to diagnose and manage cancer in dogs more effectively.

For more information, please contact:

Email: enquiries@cancandiagnostics.com

About Vet Planet Ltd.

Established in 2008, Vet Planet Ltd. is committed to supporting pet parents and veterinarians in their everyday decisions regarding care and treatment, so that every animal can look, feel, and live their best. The company is well-known and respected in over 45 countries, with a growing presence. In 2024, Vet Planet Ltd. was listed among the top 5 most innovative companies in the PET industry at the GlobalPETS Forum.

For more information, please contact:

Email: diagnostyka@vetexpert.pl

Distributed by https://pressat.co.uk/

ShareTweetPin

Related Posts

Stallion Uranium Announces Update to Previously Announced Technology Licensing Agreement
Investing

Stallion Uranium Announces Update to Previously Announced Technology Licensing Agreement

August 1, 2025
Silver Crown Announces Amendment
Investing

Silver Crown Announces Amendment

August 1, 2025
Psychedelics Market Update: H1 2025 in Review
Investing

Psychedelics Market Update: H1 2025 in Review

July 31, 2025
Psychedelics Market Update: H1 2025 in Review
Investing

Psychedelics Market Update: H1 2025 in Review

July 31, 2025
Gold Retreats, Equities Down as Fed Leaves Rates Unchanged​
Investing

Gold Retreats, Equities Down as Fed Leaves Rates Unchanged​

July 31, 2025
Gold Retreats, Equities Down as Fed Leaves Rates Unchanged​
Investing

Gold Retreats, Equities Down as Fed Leaves Rates Unchanged​

July 31, 2025
Next Post
One Night Only: Treorchy Male Choir Performs in Milton Keynes

One Night Only: Treorchy Male Choir Performs in Milton Keynes

Recommended

Ascott boosts PHL presence amid regional expansion

September 23, 2024
Could Bitcoin Reach $200000? Market & Expert Insights

Could Bitcoin Reach $200000? Market & Expert Insights

February 26, 2025
House OKs Meralco franchise renewal on final reading

House OKs Meralco franchise renewal on final reading

November 6, 2024
International online literature comes to life at the British Museum

International online literature comes to life at the British Museum

November 22, 2024
Fintech Firm Velocity Raises US$10 Million for Enterprise Stablecoin Infrastructure

Fintech Firm Velocity Raises US$10 Million for Enterprise Stablecoin Infrastructure

May 29, 2025
Enforced office mandates drive workers to seek flexible roles

Enforced office mandates drive workers to seek flexible roles

November 25, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 InvestDailyPro. All Rights Reserved.

    Disclaimer: InvestDailyPro.com, its managers, its employees, and assigns (collectively InvestDailyPro ) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    No Result
    View All Result
    • About us
    • Contact us
    • Home
    • Privacy Policy
    • Suspicious engagement
    • Terms & Conditions
    • Thank you

    Copyright © 2025 investdailypro.com | All Rights Reserved